ArticleClinical and experimental medicine2025
A novel fourth generation of CAR-T cells: CD19 CAR-T cells engineered to express membrane-bound interleukin-15 and CXCR5 for the treatment of lymphoma.
Xinping Cao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.